Skin & Hair · Skin & Hair peptide (research)
SNAP-8
- Drug class
- Skin & Hair peptide (research)
- Status
- Compounded (503A)
- Also known as
- snap 8, snap8, acetyl octapeptide-3, argireline alternative
- Reviewed
- 2026-06-01 · Kindr Health Clinical Team
What SNAP-8 is studied for
- Expression line softening (research)
- Topical use (research)
- Argireline extension (research)
Mechanism of action
SNAP-8 is being studied in the skin & hair category. Octapeptide studied topically for expression-line softening. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is SNAP-8?
SNAP-8 is a skin & hair peptide. Octapeptide studied topically for expression-line softening.
What is SNAP-8 studied for?
Published research has examined SNAP-8 for expression line softening, topical use, argireline extension. Human clinical evidence varies by indication.
Is SNAP-8 FDA-approved?
No. SNAP-8 is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is SNAP-8 used in research?
Protocols vary by study. SNAP-8 is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for SNAP-8 is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.
Related peptides in Skin & Hair
Continue across the Kindr entity graph
Related evidence, peptides, and clinical tools on the same topic.
- GHK-Cu — collagen synthesisPeptide
- AHK-Cu — skin & hairPeptide
- Tissue Clock — collagen turnoverTissue Clock